Press release
Nucleic Acid Therapeutics CDMO Market Growth Fueled by Demand for Modified Nucleic Acids, Primers, Probes, and Oligo Services
Nucleic Acid Therapeutics CDMO Market
According to the latest research by InsightAce Analytic, the global nucleic acid therapeutics CDMO market size valued at USD 2,540.9 Million in 2024 and it is expected to reach USD 8,688.2 Million by the year 2034, recording a promising CAGR of 13.2% during the period of 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1348
Nucleic acid therapeutics have become a transformative approach in the treatment of various genetic and chronic conditions, with increasing disease prevalence driving demand for DNA- and RNA-based therapies. These treatments, which are developed using deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or their derivatives, are witnessing growing clinical application, thereby fueling substantial expansion within the Contract Development and Manufacturing Organization (CDMO) sector.
To bolster capabilities in nucleic acid drug production, industry participants are actively pursuing strategic initiatives including mergers, acquisitions, collaborations, and facility expansions. A prominent example is the acquisition of GeneDesign, Inc., a leading Japanese CDMO specializing in nucleic acid therapeutics, by Ajinomoto Co., Inc. and OmniChem N.V. in December 2016. This transaction strategically reinforced the companies' presence in the nucleic acid CDMO landscape.
Market growth is further driven by rising demand for messenger RNA (mRNA)-based therapeutics, increasing global healthcare expenditures, cost efficiencies inherent in CDMO services, a growing number of regulatory approvals for nucleic acid-based drugs, and the rapid adoption of advanced nucleic acid technologies across diagnostic and therapeutic domains.
Nevertheless, the industry faces several challenges that may impede progress. Key concerns include supply chain inefficiencies, complexities in achieving targeted delivery, the need to maintain therapeutic efficacy while minimizing off-target effects, and a limited talent pool with expertise specific to nucleic acid manufacturing.
From a regional perspective, North America is projected to exhibit the most rapid growth, supported by substantial R&D investments, the emergence of innovative market players, heightened demand for nucleic acid therapies-particularly in the wake of the COVID-19 pandemic-and favorable reimbursement frameworks. Simultaneously, the Asia-Pacific region is expected to register robust expansion, driven by the increasing incidence of genetic diseases, a flourishing biopharmaceutical sector, and ongoing advancements in both medical technologies and manufacturing capabilities.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Major key players in the nucleic acid therapeutics CDMO market are Agilent Technologies, Inc., Ajinomoto Co. Inc., Bachem Holding AG., Biospring GmbH, Corden Pharma International, Danaher Corporation, Guangzhou Ruibo Biotechnology Co., Ltd., KNC Laboratories Co., Ltd., LGC Limited, Merck KGaA, Nippon Shokubai Co., Ltd., Nitto Denko Avecia Inc, QIAGEN N.V., S.T. Pharm Co Ltd, Sumitomo Chemical Co., Ltd., Syngene International Limited, Thermo Fisher Scientific Inc., Wuxi AppTec, Yamasa Corporation, Laboratorios Farmacéuticos Rovi, S.A., Sartorius AG (BIA Separations), AGC Biologics, FUJIFILM Diosynth Biotechnologies, Hanmi Pharmaceutical, Arranta Bio (Recipharm), ST Pharm, BioCina Pty Ltd., Curia Global, Inc. and Other Prominent Players.
Key Industry Developments:
• In June 2022, Merck agreed with Agilent Technologies to develop Process Analytical Technologies (PAT). Merck and Agilent Technologies are filling a void in the downstream PAT market through this partnership. Merck expands real-time monitoring and automated process control of key process parameters (CPPs) and critical quality attributes (CQAs) to downstream processing through the combination of its bioprocess portfolio with Agilent Technologies' sophisticated analytical technologies.
• In June 2022, CordenPharma expanded its xRNA capabilities at its Caponago, Italy, plant for sterile injectables. The business claims to have invested over €10 million in a new formulation, research, and manufacturing areas for Lipid Nanoparticles (LNP). The expansion will help clients go from pre-clinical to clinical development of xRNA-based treatments (mRNA, siRNA, saRNA, microRNA, etc.), accelerating the delivery of their new medicinal solutions into clinical stages and beyond.
• In Feb 2022, Recipharm has acquired Arranta Bio. The acquisition is a cornerstone of Recipharm's strategy to provide scientifically differentiated contract development and manufacturing services for ATMPs to innovative drug developers in the Biologics market. It builds on the capabilities acquired through the recently announced GenIbet transaction and the acquisition of Vibalogics.
• In June 2021, Danaher Corporation announced that it would add protein production, plasmid DNA, and mRNA services to its bulging life sciences portfolio by acquiring Aldevron. Through the acquisition, Danaher adds contract manufacturing services.
• In August 2020, Agilent Technologies Inc. announced it would extend its advanced production facility in Frederick, Colorado, that develops and produces "oligos," which are short DNA and RNA molecules used to make nucleic acid-based therapeutics. Oligos hold the potential to be used in inventing treatments for cancer, COVID-19, cardiovascular disease, rare and infectious diseases, and other conditions. The expansion has increased the current capacity for manufacturing therapeutic oligos at the Frederick site.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1348
Market Segments
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Technology
• Column-Based Method
• Microarray-Based Method
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Products
• Standard Nucleic Acid
• Micro-Scale Nucleic Acid
• Large-Scale Nucleic Acid
• Custom Nucleic Acid
• Modified Nucleic Acid
• Primers
• Probes
• Other Nucleic Acid
• Other Services
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Chemical Synthesis
• Solid-Phase Oligonucleotide Synthesis
• Liquid-Phase Oligonucleotide Synthesis
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on End-Users
• Pharmaceutical Companies
• Academic Research Institute
• Diagnostic Laboratories
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Nucleic Acid Therapeutics CDMO market revenue (US$ Million) by Country, 2022 to 2030
• U.S.
• Canada
Europe Nucleic Acid Therapeutics CDMO market revenue (US$ Million) by Country, 2022 to 2030
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Nucleic Acid Therapeutics CDMO market revenue (US$ Million) by Country, 2022 to 2030
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Nucleic Acid Therapeutics CDMO market revenue (US$ Million) by Country, 2022 to 2030
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Nucleic Acid Therapeutics CDMO market revenue (US$ Million) by Country, 2022 to 2030
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Read Overview Report- https://www.insightaceanalytic.com/report/global-nucleic-acid-therapeutics-cdmo-market/1348
Why should buy this report:
To receive a comprehensive analysis of the prospects for global Nucleic Acid Therapeutics CDMO market
To receive industry overview and future trends of global Nucleic Acid Therapeutics CDMO market
To analyse the Nucleic Acid Therapeutics CDMO market drivers and challenges
To get information on Nucleic Acid Therapeutics CDMO market size value (US$ Mn) forecast till 2030
To get detailed information on major Investments, Mergers & Acquisition in global Nucleic Acid Therapeutics CDMO market industry
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nucleic Acid Therapeutics CDMO Market Growth Fueled by Demand for Modified Nucleic Acids, Primers, Probes, and Oligo Services here
News-ID: 4102679 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
AI in Hospitality Market Surges with 12.5% CAGR as Hotels and Restaurants Priori …
"AI in Hospitality Market" is poised to grow with a CAGR of 12.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1322
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing AI in the hospitality market are:
• Technological advancement
• Increasing population
• Improving the customer experience
The following are the primary obstacles to AI in the hospitality market's expansion:
• High expenses for…
Conversational Commerce Market Exclusive Report on Current Trends and Future Ins …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Conversational Commerce Market Size, Share & Trends Analysis Report By Component (Solution, Services), Type (Chatbots And Intelligent Virtual Assistants), Deployment Mode (Cloud And On-Premises), Enterprises Size (Small And Mid-Sized Enterprises (Smes) And Large Enterprises), Business Function (Sales, Finance, HR, Operation, And IT Service Management.) And Industry (BFSI, Healthcare And Life Sciences, IT & Telecom,…
Next-Generation Biomanufacturing Market Analysis Reveals Key Trends in Continuou …
Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Next-Generation Biomanufacturing Market- by Medical Applications (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins and Other Applications), Products (Continuous Upstream Biomanufacturing Products, Single-Use Upstream Biomanufacturing Products and Downstream Biomanufacturing Products), Workflow (Upstream Biomanufacturing and Downstream Biomanufacturing), End-Users (Biopharmaceutical Companies, CMOs (Contract manufacturing organizations)/CDMOs (Contract Development and Manufacturing Organization) and Research Institutions), Trends, Industry Competition Analysis, Revenue and…
Antisense Oligonucleotide Therapeutics Market to Hit $9.1 Billion by 2034, Fuele …
According to the latest research by Insight Analytics, the global Antisense Oligonucleotide Therapeutics market was valued at USD 2.2 Billion in 2024. It is expected to reach USD 9.1 Billion by the year 2034 with a CAGR of 15.3 % during a forecast period of 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1245
Antisense oligonucleotides (ASOs) are short, single-stranded sequences of DNA or RNA engineered to bind…
More Releases for Nucleic
Nucleic Acid Testing Market Technological Breakthroughs by 2026
Global Nucleic Acid Testing Market Research Report 2020 is a historical overview and in-depth study on the current & future market of the Nucleic Acid Testing industry. The report represents a basic overview of the market status, competitor segment with a basic introduction of key vendors, top regions, product types and end industries. This report gives a historical overview of the market trends, growth, revenue, capacity, cost structure, and…
Global Nucleic Acid Based Gene Therapy Market | Global Nucleic Acid Based Gene T …
The nucleic acid-based gene therapy market comprises of sales of nucleic acid-based gene therapy products and services. Gene therapy is utilized for correcting defective genes that are accountable for disease improvement. In addition, the nucleic acid-based therapeutics are utilized to treat genetic disorders and diseases for which there prevails no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.
According to the report analysis, ‘Nucleic Acid Based…
Nucleic Acid Isolation and Purification Market to be Driven by Rising Demand of …
Nucleic acid isolation and purification is an initial step in molecular biology studies and recombinant DNA techniques. The process of isolation includes mechanical and chemical disruption, enzymatic digestion, while the purification involves combination of extraction/precipitation, chromatography, centrifugation, electrophoresis, and affinity separation. This technique has wide applications in the field of genetic engineering, life science research, forensics and molecular diagnostics. Nucleic acid isolation helps in processing of more sample in less…
Nucleic Acid Extractors Market : Global Snapshot by 2025
Nucleic acids are one of several macromolecules found in the body in addition to fats, proteins, and carbohydrates. A nucleic acid is a polymer composed of four nucleotides linked together in a long chain known as polynucleotide. A nucleic acid consists of DNA, RNA, and protein. Nucleic acid extraction and purification is widely used in next generation sequencing, nucleic acid library preparation, gene therapy research and various other areas such…
Global Nucleic Acid Market 2017-2025
IndexBox has just published a new report "World: Nucleic Acids And Their Salts - Market Report. Analysis and Forecast to 2025" ( no link?utm_source=opr ).
This report is best suitable for you if you:
• Are planning to enter a new geographical market and wish to know which one is best for your product
• Are planning to enter a new product market and want to have a detailed overview of the market…
Nucleic Acid Aptamers Market 2023 By Top Players
Companies mentioned in the research report
Some of the prominent companies in the global market for nucleic acid aptamers are Araxis Kits, LLC, Aptamer Sciences, Inc., Aptagen, LLC, Envirologix, Inc., Cytogenix Inc., Mitsui & Co. Inc., and Quest Diagnostics.
Global Nucleic Acid Aptamers Market: Overview
Aptamers are peptides or oligonucleotide molecules that bond with a specific target molecule. Nucleic acid aptamers are a special class of nucleic acid species created via rounds of…
